Skip to Content

abrdn Global Equity Impact A JETAX

Medalist Rating as of | See abrdn Investment Hub
  • NAV / 1-Day Return 14.87  /  +1.09 %
  • Total Assets 45.5 Mil
  • Adj. Expense Ratio
    1.150%
  • Expense Ratio 1.150%
  • Distribution Fee Level Average
  • Share Class Type Front Load
  • Category Global Large-Stock Growth
  • Investment Style Large Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.99%
  • Turnover 31%

USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:19 PM GMT+0

Morningstar’s Analysis JETAX

Will JETAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in abrdn Global Equity Impact A's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings JETAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 41.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S

5.38 2.4 Mil

Tetra Tech Inc

4.64 2.1 Mil
Industrials

UnitedHealth Group Inc

4.59 2.0 Mil
Healthcare

HDFC BANK LIMITED

4.36 1.9 Mil

RELX PLC

4.26 1.9 Mil
Industrials

ASML Holding NV

4.14 1.8 Mil
Technology

Merck & Co Inc

4.01 1.8 Mil
Healthcare

Usd Cash

3.99 1.8 Mil
Cash and Equivalents

NextEra Energy Inc

3.36 1.5 Mil
Utilities

Prologis Inc

3.21 1.4 Mil
Real Estate